NCT04585594

Brief Summary

The purpose of this study is to compare the effect of two educational interventions on adherence to blood pressure medications among adults with uncontrolled hypertension.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
511

participants targeted

Target at P75+ for not_applicable hypertension

Timeline
Completed

Started Sep 2020

Longer than P75 for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 16, 2020

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

October 6, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 14, 2020

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2024

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

February 24, 2026

Completed
Last Updated

February 24, 2026

Status Verified

February 1, 2026

Enrollment Period

4 years

First QC Date

October 6, 2020

Results QC Date

January 17, 2026

Last Update Submit

February 4, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Medication Adherence (Objective)

    Medication adherence is assessed at 6-month follow-up with Medication Event Monitoring System (MEMS) pill bottle cap monitors (MWV/WestRock), an objective, gold-standard measure for pill-taking behavior. MEMS caps can be affixed to a medicine bottle to record each time the bottle is opened, indicating when the patient took the medication. Daily adherence is defined as the proportion of days that the prescribed number of doses was taken by the patient during a 30-day period.

    6 months post-intervention

Secondary Outcomes (5)

  • Medication Adherence (Subjective)

    6 months post-intervention

  • Number of Participants Who Were Nonadherent Due To Beliefs (Subjective)

    6 months post-intervention

  • Medication-related Beliefs (Specific)

    5 months post-intervention

  • Systolic Blood Pressure

    6 months post-intervention

  • Diastolic Blood Pressure

    6 months post-intervention

Other Outcomes (3)

  • Medication-related Information

    Collected for analysis at baseline, upon completion of intervention period and upon completion of outcome assessment period at 1-month and 6-month follow up.

  • Medication-related Behavioral Skills

    Collected for analysis at baseline, upon completion of intervention period and upon completion of outcome assessment period at 1-month and 6-month follow up.

  • Activation of Behavioral Strategies

    Collected for analysis at baseline, upon completion of intervention period and upon completion of outcome assessment period at 1-month and 6-month follow up.

Study Arms (2)

Mi Propio Camino (MPC; My Own Way)

EXPERIMENTAL

Participants will complete the MPC intervention alongside usual care for hypertension

Behavioral: Mi Propio Camino (MPC)

Habilidades para Controlar la Presion (HCP; Skills for Blood Pressure Control)

ACTIVE COMPARATOR

Participants will complete the HCP intervention alongside usual care for hypertension.

Behavioral: Habilidades para Controlar la Presion (HCP; Skills for Blood Pressure Control)

Interventions

The Mi Propio Camino (MPC) intervention will be comprised of four sessions. Session 1 will encompass: the facts about high blood pressure (BP), understanding blood pressure readings, provide an overview of changes one can make to manage their BP, introduce MPC personal experience monitoring, and usage the mHealth kit. Subsequently, sessions 2-4 will emphasize the benefits of personal experience monitoring through 1) personal insight (finding what works for them) and 2) empowerment to work with their providers. Session 2 will reinforce this by introducing: synergy between medication and lifestyle, principles of heart-healthy eating and physical activity. Session 3 will incorporate discussion of negative beliefs about medication and patient directed lifestyle learning-rotating stations. Lastly, session 4 will introduce the continuation of personal experience monitoring on their own through the use of behavioral strategies for adherence and provider communication strategies.

Also known as: MPC
Mi Propio Camino (MPC; My Own Way)

The HCP intervention will be comprised of four sessions and introduce seven lifestyle strategies (LS) subdivided per these sessions. Session 1 will encompass the facts about high blood pressure (BP), understanding blood pressure readings, provide an overview of changes one can make to manage their BP, present specific health threats from high BP, and incorporate LS1: taking control of your medication. Subsequently, sessions 2-4 will reinforce the benefits of taking medications through presenting 1) reduced risk for complications and 2) strategies to remember to take medications. Session 2 will present LS2: eating a well-balanced, low-salt diet and LS3: enjoying regular physical activity. Session 3 will follow with introducing LS4: maintaining a healthy weight and LS5: shaking the salt habit while eating out. Session 4 will present LS6: managing stress and LS7: working together with their doctor followed by a review of strategies they can continue on their own.

Also known as: HCP
Habilidades para Controlar la Presion (HCP; Skills for Blood Pressure Control)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Health Policy Research Institute

Irvine, California, 92697, United States

Location

MeSH Terms

Conditions

HypertensionMedication Adherence

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesPatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Limitations and Caveats

Objective adherence was measured using MEMS caps, which record bottle-opening events and may not perfectly correspond to ingestion; this limitation is inherent to all electronic monitoring approaches.

Results Point of Contact

Title
John Billimek
Organization
University of California, Irvine

Study Officials

  • John Billimek, PhD

    University of California, Irvine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Faculty

Study Record Dates

First Submitted

October 6, 2020

First Posted

October 14, 2020

Study Start

September 16, 2020

Primary Completion

September 10, 2024

Study Completion

September 10, 2024

Last Updated

February 24, 2026

Results First Posted

February 24, 2026

Record last verified: 2026-02

Locations